FrontPage is India's Stock Market Social Network
Join 3,00,000+ Traders and Investors
WOCKPHARMA
201234567892012345678950123456789.9012345678950123456789
-2.20 (-0.96%)
Previous Close: 228.15
1D
5D
1M
3M
1Y
5Y
Popular Posts

Anoop

TradeAdda

TRADE WiTH TREND

#WOCKPHARMA will declare results on Jan 6, 2022 Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.

ResultsBot

Elliott Wave

Srksagar

Elliott Wave

Equity And Option Trader

#WOCKPHARMA Made high of 550 today!!

ProTip Price Action

ProTip Price Action

TechMentalAK

Elliott Wave

#WOCKPHARMA 585 to 621 : Close to given target of 635, next 675 & more..This post in Positional Trades (Swing,Momentum,Trending,Invest) channel on FrontPage

Jagdish Jha

Dharun investor

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/wockhardts-covid-19-vaccines-supply-deal-with-uk-govt-extended-for-6-months/articleshow/80786104.cms #WOCKPHARMA

NewsBot

POSITIONAL INTRADAY CALL BUY WOCKPHARM ABOVE 532 STOP LOSS 510 TGT - 540 550 570 600 #WOCKPHARMA
T

Trading And Education

Govt. May Approve Oxford-AstraZeneca Vaccine Today, After UK Grants Emergency Nod Government is likely to grant approval to the coronavirus vaccine developed by Oxford University and AstraZeneca today, after the UK gave its nod to the jab, a top source at the Central Drugs Standard Control Organisation #ASTRAZEN #WOCKPHARMA

Alpha Signals

#WOCKPHARMA AMAZING BUYING SEEN... LOCKED IN UC...

The Market Crux

GlobalGrowthMentors

#BANKINDIA #WOCKPHARMA #SBIN #KANSAINER **Wockhardt** The stock price spiked 10 percent after the company entered into an agreement with the UK government to finish COVID-19 vaccines. The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales. **Welspun Corp** The stock jumped 5 percent after the company received multiple orders across geographies, including USA, KSA and India, of approximately 106 KMT valuing close to Rs 1,000 crore. With these orders, the company's order book stands at 759 KMT valued at approximately Rs 6,200 crore after considering execution up to June 2020. **Bank of India** The stock price gained over 2 percent after the company reported Q1 net profit of Rs 843.6 crore in the quarter ended June 2020 against Rs 242.6 crore in the year ago period. Net Interest Income (NII) was down to Rs 3,481 crore versus Rs 3,485 crore. The Gross NPA was at 13.91% versus 14.78% (QoQ), reported CNBC-TV18. **State Bank of India** The stock price ended in the green after brokerages, including CLSA, Nomura and Kotak, recommended a buy call on the stock. The PSU bank reported a standalone profit of Rs 4,189.34 crore for the quarter ended June 2020, a growth of 81.2 percent over a year-ago period driven by stake sale in life insurance business. Provisions and lower non-interest income limited growth in profit. Net interest income, the difference between interest earned and interest expended, increased 16.1 percent to Rs 26,641.56 crore in June quarter compared to Rs 22,938.8 crore in year-ago period. **Vakrangee** The shares jumped 5 percent after the company's net profit rose 383 percent to Rs 31.16 crore in the quarter ended March 2020 as against Rs 6.45 crore during the previous quarter ended March 2019. Sales rose 104.41 percent to Rs 207.39 crore in the quarter ended March 2020 as against Rs 101.46 crore during the previous quarter ended March 2019. For the full year,net profit rose 182.52% to Rs 71.28 crore in the year ended March 2020 as against Rs 25.23 crore during the previous year ended March 2019. Sales declined 54.57% to Rs 685.22 crore in the year ended March 2020 as against Rs 1508.23 crore during the previous year ended March 2019. **Kansai Nerolac Paints** The share price was up over 3 percent after the company's consolidated net profit went down 79.5 percent to Rs 29.6 crore against Rs 144.7 crore YoY. Cons revenue fell 58.6 percent to Rs 639 crore against Rs 1,542.4 crore YoY. Consolidated EBITDA was down 69.7 percent at Rs 77 crore against Rs 254 crore YoY. Consolidated EBITDA margin stood at 12 percent against 16.4 percent YoY. **Teamlease Services** The stock was up over 3 percent on improving prospects of operating margins. The company's strict cost rationalisation measures and exit from subdued businesses are expected to give its margins a shot in the arm. The company reported weaker-than-expected June quarter earnings with revenue declining on a year-on-year basis, in both its key general staffing and human resource services segments. #NIFTY50

TradeAdda

https://www.moneycontrol.com/news/business/markets/wockhardt-shares-hit-10-upper-circuit-on-covid-vaccines-tie-up-with-uk-govt-5638771.html #WOCKPHARMA

NewsBot

RISKY INTRADAY SHORT WOCKPHARMA AT 222, TARGET 219, 217, SL 225. #WOCKPHARMA

The Market Crux

NewsBot

Siddharth-display-image
Reputation: 3,022  •  Nov 9 1:24 AM
Like
Comment
Share
Add a comment
Anoop-display-image
Reputation: 280  •  Oct 12 6:56 AM

#Trendline support
#Bullish harami cross
Buy
1 Like
Comment
Share
Add a comment
StockTradeX-display-image
Reputation: 4,386  •  Oct 1 5:48 AM

*Companies with Highest Revenues from Europe*
🔸Suven Pharma 81.91%
🔸Mastek 67.99%
🔸Balkrishna Inds 51.63%
🔸Wockhardt 50.31%
🔸Tata Steel 47.00%
🔸Sequent Sc. 42.06%
🔸Varroc Engg......read more
Like
Comment
Share
Add a comment
IrudayaRaj Eliyas-display-image
Reputation: 1,644  •  Sep 12 5:02 AM

looking some reversal from here
cmp 277 sl below 250 tgt 300 ,310+
made bottom and reverse with good volume
Chartbusters - chart - 12416215
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Sep 8 2:01 AM
Big Movers on D-St: What should investors do with EIH, Wockhardt & Hindustan Foods stocks?
Stocks that were in focus include names like EIH which was up over 11 per cent, Wockhardt rose more than 8 per cent, and Hindustan Foods rose nearly 6 per cent on Wednesday.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Aug 25 9:11 AM
Will restructuring US biz turnaround this pharma player?
In a regulatory filing, the company said it is closing down its manufacturing facility in Illinois, USA and will continue its business in the United States through contract manufacturing alliances for its products sold in North America.The drugmaker also said that the new arrangement is in the interest of the company as it will help avoid the manufacturing and quality management cost completely resulting in significant savings in operating and overhead costs.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Aug 20 10:08 AM
Wockhardt shuts manufacturing unit in US to cut down on costs
The closure of the Illinois-based manufacturing facility will not affect the availability of products in the US market, Wokhardt clarified.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Aug 20 8:46 AM
Wockhardt ties up with various partners to roll out products in US market
"The company is relieving all its staff who were directly engaged by our US subsidiary in its plant in connection with the manufacturing process in a phased manner and in full compliance with the applicable local laws," Wockhardt Ltd said in a regulatory filing.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Aug 16 5:43 AM
Wockhardt initiates phase-III clinical study of new antibiotic candidate
The company has completed the first site initiation visit for the study, Wockhardt said in a statement.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Aug 16 5:41 AM
Wockhardt initiates phase-III clinical study of new antibiotic candidate
WCK 5222 is a drug, which is entirely a new class of antibiotic known as "β-lactam ENHANCER", and is targeted for treatment of hospitalised adults with complicated urinary tract infections, including acute pyelonephritis, Wockhardt said in a statement.
The Economic Times
Like
Comment
Share
Add a comment
TradeAdda-display-image
Reputation: 55,057  •  Aug 16 2:22 AM

*Stocks in News*
Life Insurance Corporation of India: The life insurance major registered an increase of 20.35 percent in total premium income at Rs 98,352 crore in June FY23 quarter, against Rs 81,721 crore for the quarter ended June FY22. The profit for the quarter was Rs 682.8......read more
Like
Comment
Share
Add a comment
FinoPhia-display-image
Reputation: 6,331  •  Aug 16 2:03 AM
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Aug 3 2:21 AM
Buy Wockhardt, target price Rs 260: Sharekhan by BNP Paribas
Wockhardt Ltd., incorporated in the year 1999, is a Mid Cap company (having a market cap of Rs 3370.29 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
TradeAdda-display-image
Reputation: 55,057  •  Aug 2 8:23 AM

WOCKHARDT

Inv H&S Reversal With Uptick in volumes A

Add Cmp 235 and Dips 225 Sl 210 Trg 260 270

For Educational Purpose Only.

#TradeAdda #WOCKPHARMA
Chartbusters - chart - 11206453
4 Likes
3 Comments
Share
Add a comment
Elliott Wave-display-image
Reputation: 23,402  •  Jul 28 8:01 AM
Like
1 Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Jun 28 4:46 AM
Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US
"The over-the-counter market has long been an important segment of Glenmark's portfolio around the world. Our acquisition of these ANDAs represents the continued expansion of our business into the OTC market here in the United States and our commitment to ensuring patients have access to high quality, affordable medicines," Glenmark Pharmaceuticals Inc, USA, President Sanjeev Krishan said.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Jun 28 4:38 AM
Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US
The acquisition by the company's fully-owned subsidiary Glenmark Pharmaceuticals Inc, USA includes the approved abbreviated new drug applications (ANDAs) for famotidine tablets, 10 mg and 20 mg used to treat and prevent ulcers in the stomach and intestine, the company said in a statement.
Moneycontrol
Like
Comment
Share
Add a comment
Elliott Wave-display-image
Reputation: 23,402  •  Jun 22 5:27 AM
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  May 30 2:46 AM
Wockhardt Q4 Results: Loss widens to Rs 311 cr
Wockhardt had agreed to pay USD 36 million and interest over nine instalments between 2022 and 2025, the company said, adding its US subsidiary has already made provision of Rs 51 crore in the previous year ended March 31, 2021 and further provision of Rs 67 crore was made on September 30, 2021.
The Economic Times
Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,221  •  May 28 12:30 PM

#WOCKPHARMA will declare results on May 30, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  May 19 12:13 PM
Trade Spotlight | What should you do with MCX India, Wockhardt, MRPL, Orient Bell on Thursday?
What a classic setup we are having MCX India, precise Bullish BAT pattern on daily chart with N wave completed near potential reversal zone of Rs 1,200-1,220.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  May 4 12:31 PM
What Rakesh Jhunjhunwala, Dolly Khanna & other D-Street mavens bought & sold in Jan-Mar
Among the notable purchases were Jubilant Pharmova, Canara Bank and Indiabulls Housing, where Rakesh Jhunjhunwala increased stake by 0.2-0.5%. Jhunjhunwala has trimmed his stake in TV18 Broadcast by 0.3% and offloaded 0.2% in pharma sector firm Wockhardt.
The Economic Times
Like
Comment
Share
Add a comment
Elliott Wave-display-image
Reputation: 23,402  •  Mar 31 3:47 AM
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Mar 21 5:26 AM
Wockhardt unit partners with SII subsidiary to set up vaccine manufacturing plant in UK
The collaboration between Wockhardt UK and Serum Life Sciences UK Ltd will help create a considerable number of employment opportunities along with the creation of a new sterile fill and finish facility in Wrexham, North Wales.
The Economic Times
Like
Comment
Share
Add a comment
TRADE WiTH TREND -display-image
Reputation: 5,391  •  Mar 3 11:44 AM
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Mar 3 8:51 AM
Many Jhunjhunwala stock bets hit 52-week lows in recent D-St selloff
Edelweiss Financial Services, where the ace investor owned 1.6 per cent stake as of December 31, hit a 52-week low of Rs 53.95 on February 28. On Thursday, the stock made an intraday low of Rs 55.20.
The Economic Times
Like
Comment
Share
Add a comment
Traders Premier -display-image
Reputation: 2,324  •  Feb 25 2:33 AM

Wockhardt Ltd. LTP 340.45 Yearly Low 325.3 Near to year low 4.66%
Like
Comment
Share
Add a comment
Spoiledbrahmin-display-image
Reputation: 1,182  •  Jan 28 2:17 AM

#WOCKPHARMA : Q3 CONS NET LOSS RUPEES 68M VS 324M (YOY); 355M (QOQ)
POOR QOQ
POOR YOY
POOR EBITDA
POOR MARGINS
Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,221  •  Jan 25 12:30 PM

#WOCKPHARMA will declare results on Jan 27, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Jan 6 8:11 AM
Wockhardt board approves plan to raise Rs 1,000 cr via rights issue
he board of directors in its meeting held on Thursday considered and approved the issue of equity shares by way of a rights issue to the existing shareholders of the company for an amount not exceeding Rs 1,000 crore, it added.
The Economic Times
Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,221  •  Jan 4 12:30 PM

#WOCKPHARMA will declare results on Jan 6, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
2 Likes
Comment
Share
Add a comment
Gyanee-display-image
Reputation: 8,830  •  Nov 14, 2021 5:05 AM

Wockhardt, a research-based pharma and biotech co., posted a stellar Q2. Consolidated NP zoomed to Rs. 34 cr. from Rs. 4 cr. in Q2FY21. It won 4 patents during the quarter and has a total of 770 patents under its sleeves.
Like
Comment
Share
Add a comment
Harry-display-image
Reputation: 1,825  •  Nov 8, 2021 10:54 AM

*Wockhardt Ltd.* | *CMP* Rs. 460 | *M Cap* Rs. 5064 Cr | *52 W H/L* 805/287
(Nirmal Bang Retail Research)
*Result is ok*
Revenue from Operations came at Rs. 862 Cr (0.3% QoQ, 20.7% YoY) vs QoQ Rs. 859.6 Cr, YoY Rs. 714.1 Cr
EBIDTA came at Rs. 109.3 Cr (1.6% QoQ, 300.4% YoY) vs Qo......read more
Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,221  •  Nov 6, 2021 12:30 PM

#WOCKPHARMA will declare results on Nov 8, 2021
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
Elliott Wave-display-image
Reputation: 23,402  •  Nov 3, 2021 3:37 AM

#WOCKPHARMA EW can tell when to sell when to buy for big tg with smaller sl
WOCKPHARMA - 5661647
1 Like
Comment
Share
Add a comment
Elliott Wave-display-image
Reputation: 23,402  •  Oct 30, 2021 8:22 AM
Like
Comment
Share
Add a comment
Harry-display-image
Reputation: 1,825  •  Oct 26, 2021 3:55 AM

WOCKHARDT: CATALYST TRUSTEE SHIP ACQUIRED 2.35M SHARES (2.12% OF EQUITY) ON OCT. 21
Like
Comment
Share
Add a comment
Ashish-display-image
Reputation: 0  •  Oct 22, 2021 5:27 AM

Buy at 452 for the target 472
Keep S.L of 445
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Oct 19, 2021 3:16 AM
UK PM Boris Johnson hails India's Wockhardt as vaccine rollout success story
During a flagship speech at the Global Investment Summit at London's Science Museum, Johnson said Wockhardt's Wales-based bottling plant was instrumental in ensuring the vaccination programme was a success.
The Economic Times
Like
Comment
Share
Add a comment
Srksagar-display-image
Reputation: 64,826  •  Oct 10, 2021 6:52 AM

#WOCKPHARMA Moved up with increase in volumes ,can test 592,677,804
Chartbusters - chart - 5169511
3 Likes
Comment
Share
Add a comment
A
Reputation: 216  •  Oct 10, 2021 4:01 AM

Buy Call... 💯💥💯💥 Must Buy!! Immediately.
#WOCKPHARMA 💯 (open upto 1500)
#ENGINERSIN 💯 ( open upto 600)
#BankOfBaroda💥 (open upto 300)
#BHARTIARTL 💥 (open upto 1000)
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Oct 8, 2021 5:06 AM
Wockhardt jumps 11% amidst stake sale buzz
Reports said Covishiled manufacturer SII may buy 10 per cent stake, valuing the Wockhardt at Rs 7,000 crore. The current market-cap of the company stands at Rs 5,691.08 crore.
The Economic Times
Like
Comment
Share
Add a comment
Deepak Choudhary-display-image
Reputation: 1,345  •  Sep 29, 2021 6:29 AM

$WOCKPHARMA consolidating at its support can show big move
Entry : 450
Target : 787
Stop loss : 385

#WOCKPHARMA #TradingUniversity
WOCKPHARMA - 4940036
Like
Comment
Share
Add a comment
Tmt View-display-image
Reputation: 4,043  •  Sep 27, 2021 3:50 AM

(TMT) WOCK PHARMA (CLOSE 445.95):- It's near important trend line resistance zone enter above 455 possible tgt 550+ support zone 430. #WOCKPHARMA
WOCKPHARMA - 4890256
Like
Comment
Share
Add a comment
Elliott Wave-display-image
Reputation: 23,402  •  Sep 23, 2021 4:04 AM
7 Likes
2 Comments
Share
Add a comment
Equity And Option Trader-display-image
Reputation: 37,695  •  Aug 27, 2021 11:16 AM

#WOCKPHARMA, seeing that there's too much fuss about this stock on Twitter. According to MTF chart, stock has broken all supports and is in clear cut downtrend and entered the consolidation channel of 200-400 in which stock is likely to remain until closes above 600. Avoid!
WOCKPHARMA - 4398706
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Aug 14, 2021 3:16 AM
Wockhardt, Enso Health join hands for Sputnik jabs
Drug maker Wockhardt said on Friday that it partnered with Enso Healthcare, an aggregator for Russian Direct Investment Fund (RDIF) for its Covid-19 vaccine, to produce and supply Sputnik V and Sputnik Light.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,898  •  Jul 22, 2021 9:16 AM
Wockhardt Q1 results: Company reports Rs 6.58 crore loss
Consolidated revenue from continuing operations of the company stood at Rs 859.55 crore for the quarter under consideration against Rs 598.27 crore for the same period a year ago, the filing said.
The Economic Times
Like
Comment
Share
Add a comment